Product development by New York Cryogen, Inc.
AC-130 Viper
The AC-130 Viper is under development and is not available for commercial distribution in the
United States. Final specifications, intended use, labeling, and availability remain subject to
regulatory review and may change.
Quick Contact
Email : bill@nycryogen.com Phone : 516-382-9110
Relieve Pain, Reduce Inflammation, and Recover Faster
Developing the AC-130 Viper
Instant Pain Relief
Targeted Cold Therapy Designed to apply rapid, targeted cooling to a specific treatment area.
Precision Technology
High-pressure CO2 delivery with adjustable pressure and real-time temperature monitoring.
Product Development in Progress
Receive official company announcements about product development and regulatory status. Joining
the update list does not reserve or purchase a product and does not schedule a treatment or
consultation.
Design work is ongoing. Final product configuration and public product information will be updated
only after the applicable reviews are complete.
Recovery Support
High-Pressure Medical Cryotherapy is designed to help calm inflammation and support the recovery process.
Targeted Vascular Response
The treatment is designed to trigger a localized vascular response in the treated area.
Ergonomic Design
- The device is partially encased in medical grade plastic and features a medical grade silicone handle for excellent tactile feedback, ensuring a comfortable and secure grip.
Advanced Nozzle Technology
- The AC-130 Viper is equipped with four 100% pure titanium nozzles that are cone spray pattern including two rocket for ultra high power. Also referred as the “Rocket Nozzle” technology.
- All nozzles are adjustable to a full 180 degrees, allowing for precise treatment techniques.
- The nozzles feature non threaded heads with a secure push and locking mechanism, ensuring a 100% seal every time.
Exceptional Build Quality
- Crafted from a solid block of stainless steel, the main body of the device is CNC milled to perfection. NOTHING is welded together.
- Unlike all other devices that have fully plastic components, the AC-130 Viper is virtually indestructible, guaranteeing longevity and durability.
Pressure Control
- Fully adjustable pressure from 1 psi to 1000 psi so you always are in control of the treatments
Precision Guidance
- 2 blue lasers that converge at 8 inch distance to give you a clear reference point on the treatment area
User Friendly Interface
- A 10 inch touch screen monitor that can be tank or wall mounted displays the treatment time and skin temperature.
Mobility and Convenience
- The entire system comes with a padded backpack that holds the entire system. 20lb (scuba size) or 35lb (medium sized) Co2 tanks can easily be transported in just about any vehicle for in home treatments.
Heating Element
- A heating element helps to prevent the nozzles from freezing and clogging.
Surface temperature sensors
- Built in temperature sensors built into the device that constantly monitor the surface temperature where it’s pointed.
Separate Thermographic Camera
- To give you a more complete view of the skin temperature for the entire treatment area.
Viper Skin
- Our translucent silicone sheathing material that protects the tissue and makes the treatments comfortable for the patients.
Key Features of the AC-130 Viper
The AC-130 Viper is designed to deliver High-Pressure Medical Cryotherapy with precise control over pressure, temperature, and treatment area.
Engineering & Innovation
Precision engineering drives the design of the AC-130 Viper.
Personal Journey & Resilience
A breakthrough solution born from overcoming extreme pain.
High-Pressure Cryotherapy
High-pressure CO2 technology designed for deep, targeted cold therapy.
FDA Clearance In Progress
The AC-130 Viper is under development and is not available for commercial distribution in the United States.
Transform Your Pain Relief Journey
The AC-130 Viper is under development and is not available for commercial distribution in the United States.
Product specifications, intended use, labeling, and availability remain subject to regulatory review and may change.
Podcast
Listen to our PodCast
